Heron Therapeutics Inc (HRTX)

Heron Therapeutics Inc Azioni (HRTX) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	8.90% 34.23	31.43	31.76	29.61	30.03
Cost Of Revenue	45.71% 9.885	18.21	20.16	16.85	12.63
Gross Profit	84.09% 24.35	13.23	11.60	12.76	17.40
Operating Expenses	9.40% 34.57	38.16	54.01	45.82	37.76
Benefits Costs and Expenses	9.40% 34.57	38.16	74.17	62.68	50.38
Costs And Expenses	9.40% 34.57	38.16	74.17	62.68	50.38
Operating Income/Loss	59.00% -10.22	-24.93	-42.40	-33.06	-20.36
Income/Loss From Continuing Operations Before Tax	95.02% -0.335	-6.721	-42.06	-32.77	-20.36
Income/Loss From Continuing Operations After Tax	57.12% -10.72	-25.01	-42.06	-32.77	-19.87
Net Income/Loss	57.12% -10.72	-25.01	-42.06	-32.77	-19.87
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	96.97% 4.388	144.99	119.72	119.25	-105.35
Diluted Average Shares	96.97% 4.388	144.99	119.72	119.25	-105.35
Basic Earnings Per Share	70.59% -0.05	-0.17	-0.35	-0.27	-0.13
Diluted Earnings Per Share	70.59% -0.05	-0.17	-0.35	-0.27	-0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-